To test this in clinically relevant material, we used an ex vivo human tumour culture assay, where treatment of PCa tissue explants with bicalutamide or enzalutamide had no effect on proliferation index (measured by Ki67), but proliferation was strongly repressed by the combination of Olaparib with bicalutamide or enzalutamide (P < 0.05) (Fig. 4c, d). The gene discussed is MKI67; the disease is posterior cortical atrophy.